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Drug-Phospholipid Complex-loaded Matrix Film Formulation for the Enhanced
Transdermal Delivery of Quercetin
Abstract
A novel quercetin-phospholipid-complex(QPLC)-loaded matrix film for improved transdermal delivery of
quercetin was developed. The QPLC formulation, prepared using a solvent-evaporation method, was
optimized using a central-composite design. The optimized QPLC formulation was characterized by
particle size and zeta potential analysis, thermal analysis, Fourier transform infrared spectroscopy (FTIR),
and proton nuclear magnetic resonance spectroscopy (1H-NMR). QPLC formulation was functionally
evaluated for solubility and in vitro dissolution of quercetin. Matrix films of pure quercetin (Q-MF)or QPLC
QPLC-MF) were prepared using a solvent casting method. The prepared Q-MF and QPLC-MF were
characterized for weight uniformity, folding endurance, moisture content, and moisture uptake. The films
were also functionally characterized for in vitro diffusion of quercetin through a dialysis membrane and ex
vivo permeability of quercetin across rat skin. Finally, the anti-inflammatory activity of the films was
evaluated on carrageenan-induced paw edema in Wistar albino rats. The experimental design identified
the optimal formulation and process variables for the preparation of QPLC. The validation of the obtained
model using these values confirmed the suitability and robustness of the model. The physical-chemical
characterization of the prepared QPLC supported the formation of a stable complex. The solubility
analysis of QPLC showed a 22-fold increase in quercetin aqueous solubility, compared to pure quercetin.
The dissolution results exhibited a significantly higher rate and extent of quercetin dissolution from QPLC
compared to that of pure quercetin. The permeability of quercetin from Q-MF and QPLC-MF across rat
skin mirrored those obtained from the dissolution studies. Topical application of QPLC-MF exhibited a
significant (p<0.05) inhibition of carrageenan-induced paw edema in rats compared to that of Q-MF. This
study provides a promising combination approach, i.e., phospholipid-based complexation and
transdermal film formulation for improved transdermal delivery of quercetin and similar
pharmacologically active phytoconstituents.

Disciplines
Pharmacy and Pharmaceutical Sciences

Comments
This Journal is © IPEC-Americas. This article is also available through the publisher's website.

Creative Commons License
This work is licensed under a Creative Commons Attribution-No Derivative Works 4.0 International
License.

Authors
Darshan R. Telange, Kuldeep D. Wavare, Arun T. Patil, Milind J. Umekar, Sridhar Anand, and Vivek S. Dave

This article is available at Fisher Digital Publications: https://fisherpub.sjf.edu/pharmacy_facpub/168

Drug-phospholipid complex-loaded matrix film formulation for
enhanced transdermal delivery of quercetin.
Darshan R. Telangea, Kuldeep D. Wavarea, Arun T. Patila, Milind J. Umekara, Sridhar Anandb,
Vivek S. Daveb*
a

Smt. Kishoritai Bhoyar College of Pharmacy, New Kamptee, Nagpur, Maharashtra, India
St. John Fisher College, Wegmans School of Pharmacy, Rochester, NY, USA

b

Original Article

Received: March 18, 2018; Accepted: April 11, 2018
ABSTRACT

A novel quercetin-phospholipid-complex (QPLC)-loaded matrix film for improved transdermal delivery of quercetin was
developed. The QPLC formulation, prepared using a solvent-evaporation method, was optimized using a central-composite
design. The optimized QPLC formulation was characterized by particle size and zeta potential analysis, thermal analysis,
Fourier transform infrared spectroscopy (FTIR), and proton nuclear magnetic resonance spectroscopy (1H-NMR). QPLC
formulation was functionally evaluated for solubility and in vitro dissolution of quercetin. Matrix films of pure quercetin
(Q-MF) or QPLC (QPLC-MF) were prepared using a solvent casting method. The prepared Q-MF and QPLC-MF
were characterized for weight uniformity, folding endurance, moisture content, and moisture uptake. The films were also
functionally characterized for in vitro diffusion of quercetin through a dialysis membrane and ex vivo permeability of quercetin
across rat skin. Finally, the anti-inflammatory activity of the films was evaluated on carrageenan-induced paw edema in
Wistar albino rats. The experimental design identified the optimal formulation and process variables for the preparation of
QPLC. The validation of the obtained model using these values confirmed the suitability and robustness of the model. The
physical-chemical characterization of the prepared QPLC supported the formation of a stable complex. The solubility analysis
of QPLC showed a 22-fold increase in quercetin aqueous solubility, compared to pure quercetin. The dissolution results
exhibited a significantly higher rate and extent of quercetin dissolution from QPLC compared to that of pure quercetin. The
permeability of quercetin from Q-MF and QPLC-MF across rat skin mirrored those obtained from the dissolution studies.
Topical application of QPLC-MF exhibited a significant (p<0.05) inhibition of carrageenan-induced paw edema in rats
compared to that of Q-MF. This study provides a promising combination approach, i.e., phospholipid-based complexation
and transdermal film formulation for improved transdermal delivery of quercetin and similar pharmacologically active
phytoconstituents.
KEY WORDS: Quercetin, phospholipid, solubility, permeability, transdermal, excipients

INTRODUCTION

Quercetin is a lipophilic molecule that belongs to
the class of plant derived flavonoids (1-4). Studies
have reported quercetin to elicit a wide range of
*Corresponding address: St. John Fisher College, Wegmans School of Pharmacy,
Rochester, NY, 14534, Tel: 1-585-385-5297, Fax: 1-585-385-5295, E-mail:
vdave@sjfc.edu
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pharmacological activities including, anti-hypertensive,
anti-inflammatory, anti-proliferative, anti-diabetic,
anti-neural disorders, and importantly anti-oxidant
activity attributed to quenching of free-radicals by
quercetin (5-12). Despite promising pharmacological
effects, quercetin displays low bioavailability owing to
its poor solubility in water (~1-7 μg/mL), simulated
gastric juice (~ 5.5 μg/mL), and simulated intestinal
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juice (~29 μg/mL) (13). It is thus appropriately
classified as a BCS Class II drug. Furthermore, the
oral bioavailability of quercetin has been reported
to be negatively influenced by extensive first-pass
metabolism. The bioavailability of quercetin after oral
administration was reported to be only about 1% in
humans (14-16). Novel formulation strategies are thus
needed to improve the bioavailability of quercetin.
Among the recently explored formulation strategies
for improving quercetin bioavailability include
nanotechnology based formulations, polymeric
micelles, microspheres, and solid dispersions (4, 1720). Hatahet et. al. prepared nanocrystal-based dermal
gel formulation with quercetin, and demonstrated
enhanced solubility and dissolution of quercetin in these
formulations (7). The protective effect of quercetin on
hydrogen peroxide induced toxicity on epithelial cell
lines was also demonstrated. Wang et. al. evaluated
a solid non-aqueous self-double emulsifying drug
delivery system for the topical application of quercetin
(21). The study showed a significant improvement in
the permeability and accumulation of quercetin in the
skin. Zhang et. al. developed a combined novel drug
delivery system for improving the bioavailability and
prolonging the retention time of curcumin in the body
(22). Cai et. al. prepared huperzine A-phospholipids
complex-loaded biodegradable thermosensitive gel
PLGA-PEG-PLGA polymer gel as implant system for
controlled release of huperzine A (23). Transdermal
delivery is a promising strategy to bypass the firstmetabolism associated with oral administration. While
the approaches explored in the studies mentioned above
overcome a specific barrier to improve bioavailability i.e.
solubility or permeability enhancement, a systematic,
design-optimized, formulation development approach,
complemented with detailed evaluation, is still needed.
Previously, studies have shown drug-phospholipids
complexation as a successful approach for enhancing
the aqueous solubility, permeability, and in vivo
bioavailability of pharmacoactive molecules (23-29).
In the current study this approach was taken a step
further. Using a two-step approach, a phospholipidbased complex of quercetin was first prepared. This
This Journal is © IPEC-Americas

prepared complex was then formulated into polymeric
matrix films. The quercetin phospholipid complex
formulation (QPLC) was prepared and optimized
using a central composite design. The design-optimized
formulation was characterized by particle size and
zeta potential analysis, thermal analysis, Fourier
transform infrared spectroscopy (FTIR), proton
nuclear magnetic resonance spectroscopy (1H-NMR),
powder x-ray diffractometry (PXRD), and solubility
analysis. The dissolution behavior of QPLC was also
compared to pure quercetin. The QPLC was then
formulated into hydroxypropyl methyl cellulose-based
matrix films (QPLC-MF) using a solvent casting
method. The prepared films were then evaluated
for physical properties such as thickness, weight
variation, moisture content, and moisture uptake.
The films were functionally characterized for in vitro
diffusion across a dialysis membrane and ex vivo
permeation across rat skin. Finally, the QPLC-loaded
film was pharmacologically evaluated for in vivo antiinflammatory activity.
Materials and methods
Materials

Quercetin dihydrate (>99% purity) was obtained
from Sisco Research Laboratories Pvt. Ltd., Mumbai,
India. Phospholipon® 90H was obtained from Lipoid,
Ludwigshafen, Germany. Carrageenan was obtained
from Sigma-Aldrich Corporation, St. Louis, MO.
Chloroform, dibutyl phthalate, dimethyl sulfoxide
(DMSO), ethanol, n-hexane, hydroxypropyl methyl
cellulose (HPMC E15) and methanol were obtained
from Loba Chemicals Pvt. Ltd., Mumbai, India. Other
chemicals used in the study were of analytical grade.
The formulation
complex (QPLC)

of

the

quercetin-phospholipid

The quercetin-phospholipids complex (QPLC) was
prepared by a solvent evaporation method reported
previously (26). Briefly, quercetin and Phospholipon®
90H were weighed individually in molar ratios
of 1:0.55, 1:1.05, 1:1.78, 1:2.51 and 1:3.00 and
transferred to a 100 mL reflux flask. To this mixture
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20 mL absolute ethanol was added and mixed well.
The temperature of the flask was controlled at 40.4,
44.4, 50.1, 56.2, or 60.2°C using a water bath. The
reflux reaction was allowed to continue for 1.0, 1.4,
2.1, 2.6 or 3.0 hours. After the reaction was complete,
the flask contents was evaporated until a ~ 2-3 mL
residue remained. 10 mL of n-hexane was added to this
residue, resulting in the precipitation of the formed
QPLC. The resultant QPLC was filtered and dried at
40°C for 12 hours using vacuum drying. Finally, the
dried QPLC powder was placed in an amber (lightprotected) glass vial, flushed with nitrogen and stored
at room temperature until further characterization.

X2 and X3 represents the main effects of the independent
variables individually. The combined terms, X1 X2, X2
X3 and X1 X3 shows the interactions between the
variables. The polynomial terms, X 12, X 22 , and X 32
indicates the non-linearity of the responses. The
experimental design with coded levels and the real
values of the independent variables are shown in
Table 1. The results of the quercetin inclusion efficiency
obtained from the design generated experimental trials
are shown in Table 2.
Table 1 Coded levels and real values for independent variables
VARIABLES

Optimizing variables (central composite design)

2
3

b33 X + b12 X 1 X 2 + b23 X 2 X 3 + b13 X 1 X 3

0

+1

+1.73

Real values

Quercetin : phospholipids ratio
(X1, w: w)

1: 0.55

1:1.05

1:1.78

1:2.51

1:3.00

Reaction temperature (X2, °C)

40.4

44.4

50.1

56.2

60.2

Reaction time (X3, h)

1.0

1.4

2.1

2.6

3.00

Dependent
Extent of complexation or Yield
(Y, % w/w)

Table 2 Quercetin inclusion efficiency obtained from the designgenerated experimental trials.

Eq. 1

Where, Y and b represents the quercetin inclusion and
the estimated coefficient of the term, X respectively. X1,
This Journal is © IPEC-Americas

-1

Independent

In line with previously published reports, a central
composite design (Design-Expert®, Version 10.0.4.0,
Stat-Ease Inc., Minneapolis, Minnesota, USA) was used
to minimize the number of experiments and achieve
the maximum possible information about the prepared
formulation. Based on previous experience with similar
studies, three independent variables, i.e. quercetin:
phospholipid ratio (X1, w/w), reaction temperature (X2,
°C), and reaction time (X3, h) were selected. Each of
these variables were studied at three levels, numerically
designated as -1 (low), 0 (middle), and +1 (high). The
extent of quercetin inclusion (% yield) was chosen
as the dependent variable. The software-generated
design recommended 20 different combinations of
independent variables. Thus, 20 experimental trial
formulations were prepared and evaluated for quercetin
inclusion. Upon analysis of data, the design showed the
results in the form of a statistical model/polynomial
Equation 1 shown below. The equation describes the
significance of the coefficients of magnitude, and the
interaction and polynomial terms useful in selecting
the optimal levels of independent variables.
Y = b0 + b1 X 1 + b2 X 2 + b3 X 3 + b11 X 12 + b22 X 22 +

LEVELS
-1.73

June 2018

EXPERIMENTAL
TRIALS

X1

X2

X3

QUERCETIN
INCLUSION
EFFICIENCY
(%, w/w)
65.23 ± 0.10

1

-1

+1

+1

2

0

-1.73

0

97.57 ± 0.16

3

0

+1.73

0

72.25 ± 0.23

4

0

0

0

95.38 ± 0.11

5

-1.73

0

0

68.50 ± 0.04
94.92 ± 0.22

6

0

0

0

7

-1

-1

-1

72.10 ± 0.45

8

0

0

-1.73

96.48 ± 0.15
56.38 ± 0.33

9

-1

+1

-1

10

+1

-1

+1

94.33 ± 0.19

11

0

0

0

94.29 ± 0.21

12

+1

-1

-1

83.03 ± 0.18

13

0

0

0

95.38 ± 0.75
95.38 ± 0.75

14

0

0

0

15

+1

+1

+1

86.60 ± 0.05

16

0

0

0

95.38 ± 0.15

17

+1.73

0

0

87.40 ± 0.20

18

+1

+1

-1

88.39 ± 0.16

19

0

0

+1.73

90.80 ± 0.03

20

-1

-1

+1

87.48 ± 0.10
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Estimation of the quercetin inclusion in the prepared
complex

The extent of the quercetin inclusion in the prepared
complex was determined by a slightly modified method
to that described previously (26). Briefly, an accurately
weighed amount of the prepared QPLC (containing
~ 50 mg quercetin) was dispersed into 5 mL chloroform.
The QPLC and any unused Phospholipon® 90H were
readily dissolved in the chloroform. The unused (pure,
non-complexed quercetin) remained undissolved, and
was separated as a precipitate. This precipitate was
separated by filtration (Whatman® quantitative filter
paper, ashless, Grade 41, Sigma-Aldrich Corporation,
St. Louis, MO), and dried at room temperature. The
dried residue was dissolved in sufficient methanol, and
after suitable dilutions, analyzed spectrally (Model:
V-630, JASCO International Co., Ltd., Tokyo, Japan)
at a wavelength of 381.2 nm. The amount of quercetin
incorporated in the prepared QPLC was calculated
using Equation 2.

Quercetin inclusion (%)=

Ct −C f
Ct

x 100

Eq. 2

Where, Ct is the total theoretical amount of quercetin
in QPLC used, and Cf is the amount of quercetin in
the filtrate.
Preparation of the quercetin or QPLC-loaded matrix
film formulation (Q-MF or QPLC-MF)

The quercetin or QPLC-loaded matrix films were
prepared using a solvent casting method reported
previously (30). Briefly, accurately weighed HPMC
E15 (700 mg) was dispersed in a mixture of methanol:
chloroform (1:1, 10 mL) using a magnetic stirrer
until a homogeneous dispersion was formed. To this
polymeric dispersion, dibutyl phthalate (plasticizer, 2
mL) and dimethyl sulfoxide (permeation enhancer,
0.5 mL) was added. The dispersion was stirred well to
ensure the removal of air bubbles, if any. An accurately
weighed amount of Q-MF (containing ~30 mg of
quercetin) or QPLC (containing ~30 mg of quercetin,
prepared earlier) was added to this dispersion stirring
This Journal is © IPEC-Americas

continuously to ensure that the quercetin or QPLC
particles were uniformly distributed throughout
the polymeric dispersion. This polymeric dispersion
containing quercetin or QPLC was then poured
into a pre-fabricated, circular glass well placed in
a glass petri dish filled three fourths with mercury.
The mold was covered with inverted glass funnel to
qualitatively control the rate of solvent evaporation.
The assembly was placed in a solvent hood overnight to
facilitate solvent evaporation, and obtain dried films.
The obtained dry matrix films were then packed in
aluminum foil and stored in desiccators at a controlled
temperature (25°C) until further use.
Physical-chemical characterization of QPLC
Particle size and zeta potential analysis

The particle size and zeta potential analysis of the
design-optimized QPLC formulation was carried
out using methods reported previously (28). Photon
Cross Correlation Spectroscopy (PCCS) together
with dynamic light scattering was used to evaluate the
particle size distribution of the QPLC formulation.
An aqueous dispersion (0.5 mg/mL) of QPLC was
prepared and examined using a particle size analyzer
(Model: NANOPHOX Sympatec, GmbH, ClausthalZellerfeld, Germany). The equipment was sensitive
in the range of 1 nm to 10 µm, and flexibility of
positioning the sample to optimize the count rate
using the associated software. A nano particle analyzer
(NanoPlusTM-2, Particulate system, Norcross, GA,
USA) equipped with dynamic light scattering was
used to measure the zeta potential of the QPLC
formulation. The measurements were conducted at
room temperature within the equipment sensitivity
range of -200 to 200 mV.
Thermal analysis

Differential scanning calorimetry (DSC) was used
for comparative thermal characterization of the pure
quercetin, Phospholipon® 90H, the physical mixture
of quercetin and Phospholipon® 90H, and the designoptimized QPLC formulation. The instrument
(Model: DSC-1 821e, Mettler-Toledo AG, Analytical,
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Schwerzenbach, Switzerland) was pre-calibrated for
heat flow and heat capacity with high-purity indium
standard. The sample chamber was continuously
purged with nitrogen (50 mL/min). Individual samples
(2.0 ± 0.2 mg) were subjected to a single heating cycle
in the range of 40 to 400°C at the rate of 10°C/min.
The DSC thermograms obtained for each sample were
analyzed with the software (Universal Analysis 2000,
V4.5A, build 4.5.0.5) accompanying the instrument.
Fourier transform infrared spectroscopy (FTIR)

Pure quercetin, Phospholipon® 90H, the physical
mixture of quercetin and Phospholipon® 90H, and
the design-optimized QPLC formulation were further
chemically characterized and compared using an FTIR
spectroscopy. The samples were tested using an FTIR
spectrophotometer (Model: FTIR-8300, Shimadzu,
Kyoto, Japan). Sample preparation involved preparing
potassium bromide (KBr) pellets containing ~2 mg
air-dried samples. Thin transparent discs of KBr were
compressed on a Mini Hand Press (Model: MHP -1,
P/N – 200-66747-91, Shimadzu, Kyoto, Japan) at a
pressure of 10 ton/Nm2. Individual sample discs were
scanned within a wavelength ranging from 4000 to 400
cm-1, with a scan resolution of 4 cm-1. The obtained
spectra were analyzed by the software (IRsolution
FTIR control software, version 1.10) associated with
the instrument.
Powder X-ray diffractometry (PXRD)

The comparative crystalline nature of pure quercetin,
Phospholipon® 90H, the physical mixture of quercetin
and Phospholipon® 90H, and the design-optimized
QPLC formulation were studied using a PXRD on a
x-ray diffractometer (Model: D8 ADVANCE, Bruker
AXS, Inc., Madison, WI, USA) equipped with BraggBrentano geometry (θ/2θ) optical setup. The method
reported previously was used to analyze the samples
(28).
Proton nuclear magnetic resonance spectroscopy
(1H-NMR)

The structural framework of individual samples
This Journal is © IPEC-Americas

as well as the prepared QPLC formulation was
analyzed by proton NMR using a 400 MHz FTNMR spectrophotometer (Model: Bruker Advance II,
Bruker, Rheinstatten, Germany) with an operational
temperature range of -90°C to 80°C.
Solubility analysis

The aqueous and non-aqueous solubility of pure
quercetin, as well as quercetin in the physical mixture
with Phospholipon® 90H, or in the prepared QPLC
was determined using a procedure established
previously (27). Briefly, 5 mL dispersions of samples
were prepared in purified water or n-octanol and
agitated on a water bath shaker (Model: RSB-12, Remi
House, Mumbai, India) for 24 hours. The dispersions
were then centrifuged at 1500 RPM for 25 minutes
at ambient temperature (25°C). The dispersions, after
centrifugation, were filtered using a membrane filter
(0.45 µm). The filtrates, after appropriate dilution with
water or methanol were assayed spectrally at 381.2 nm
using UV-visible spectrophotometer (Model: V-630,
JASCO International Co., Ltd., Tokyo, Japan).
Physical-chemical characterization of QPLC-MF

The physical-chemical attributes of the prepared
QPLC-loaded matrix films were evaluated using
various methods described below.
Film thickness and weight variation

The thickness of the prepared QPLC-loaded matrix
films (surface area at 1.0 cm2) was measured using a
digital thickness gauge (Model: 500-JD, Electromatic
Equipment Co., INC. Cedarhurst, NY, USA). The
measurements were carried out in triplicate and the
mean calculated. The same films were used for weight
variation study. The films were weighed using a digital
balance (Model: CAS -164, serial no.1502677, capacity
~160g, sensitivity ~0.1mg, Contech® Electronic
Balance, Contech Instrument Pvt., Ltd., Mahape,
Navi Mumbai) and calculating the average weight of
six films.
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Folding endurance

The prepared films were evaluated for folding endurance
using a well-established procedure (30). A 6 cm2 film
is repeatedly folded at the same location multiple times
until it breaks. The number of foldings required to
break a film is described as the folding endurance. All
measurements were carried out in triplicate.
Quercetin content in QPLC-MF

Functional characterization of QPLC and QPLC-MF

The quercetin content of the prepared QPLC-loaded
matrix films was determined after extracting quercetin
from a film sample of fixed dimensions (1 cm2).
Briefly, the film was cut, weighed and transferred to
a volumetric flask containing sufficient quantity of
methanol. The flask contents were agitated on a water
bath shaker (Model: RSB-12, Remi House, Mumbai,
India) for 24 hours at 37°C. After 24 hours, the flask
contents were filtered (Whatman® quantitative filter
paper, ashless, Grade 41, Sigma-Aldrich Corporation,
St. Louis, MO), the filtrate diluted suitably, and the
solutions assayed spectrally at 381.2 nm on a UVvisible spectrophotometer (Model: V-630, JASCO
International Co., Ltd., Tokyo, Japan).
QPLC-MF moisture content

The moisture content of the prepared films was
determined using the standard procedure reported
earlier (30). Each sample formulation film (random
triplicates of same dimensions) were individually
weighed (initial weight) and placed in desiccators at a
constant temperature (25°C). The films were weighed
at regular intervals until a constant weight (final weight)
for each film was achieved. The moisture content (%)
was calculated using Equation 3.
Moisture content (%)=

Final weight of film − Initial weight of film
x 100
Initial weight of film

Eq. 3

QPLC-MF moisture uptake

The hygroscopicity (extent of ambient moisture

This Journal is © IPEC-Americas

uptake) of a film formulation is a good indicator of the
physical stability of the films. To assess the moisture
uptake of the prepared QPLC-loaded matrix films,
the pre-weighed film samples of fixed dimensions were
exposed to elevated humidity condition (saturated
NaCl solution, ~75% RH). The samples were weighed
at regular intervals until a constant weight was achieved
(final weight). The moisture uptake (%) was calculated
using Equation 3.

As described below, the prepared complex (QPLC) was
first characterized for the in vitro release and diffusion of
quercetin across a dialysis membrane. Subsequently, the
prepared QPLC-loaded matrix film (QPLC-MF) was
characterized for in vitro diffusion of quercetin across
a dialysis membrane, ex vivo permeation efficiency of
quercetin across rat abdominal skin membrane, and in
vivo anti-inflammatory activity in rats.
In vitro dissolution studies

The dissolution profiles of pure quercetin and the
prepared complex (QPLC) were compared using
a dialysis method described earlier by Maiti et.
al. (31). The dialysis membrane (LA395, dialysis
membrane-110, average diameter ~21.55 mm, average
flat width ~32.34 mm, capacity ~3.63 mL/cm;
HiMedia Laboratories, Mumbai, India) was pre-treated
and rinsed according to the manufacturer’s guidelines.
The molecular size cut off of the dialysis membrane was
12000 – 14000 Da. The dialysis bags were prepared and
loaded with samples i.e., pure quercetin suspension in
phosphate buffer saline (PBS, pH 7.4, containing ~5
mg quercetin) or QPLC (containing ~5 mg quercetin).
The sample loaded bags were vertically suspended in a
beaker containing PBS (200 mL, pH 7.4) and Tween®
20 (1% w/w) as a dissolution medium. The assembly
was stirred at 50 RPM, and the temperature of the
dissolution medium was maintained at 37.0 ± 2.0°C.
At regular intervals, aliquots (5 mL) of the dissolution
medium were removed, diluted suitably with PBS, and
absorbance recorded at 381.2 nm (ƛmax for quercetin
in PBS, pH 7.4) on a UV-visible spectrophotometer
(Model: V-630, JASCO International Co., Ltd.,
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Tokyo, Japan).

the receptor compartment maintained at 32.0 ± 0.5°C.

In vitro diffusion studies

At predetermined intervals, aliquots of samples were
retrieved from the receptor compartment, diluted and
assayed at 381.2 nm on a UV-visible spectrophotometer
(Model: V-630, JASCO International Co., Ltd.,
Tokyo, Japan) to determine the cumulative amount of
quercetin permeated through the rat skin membrane.

The in vitro diffusion of quercetin from the quercetinloaded matrix films (Q-MF) and QPLC-loaded matrix
film (QPLC-MF) were determined using a method
reported previously by Parhi et. al. (32). The studies
were carried out using a Franz diffusion cell with an
exposed surface area of 3.8 cm2. The dialysis membrane
of the specifications described above was pre-soaked
(overnight) in phosphate buffer (pH 7.4) before
using in experiments. On the day of the experiment,
the membrane was mounted between the donor and
the receptor compartment of the cell. The receptor
compartment was filled with PBS (22 mL, pH 7.4),
magnetically stirred at 200 RPM, and maintained at
32.0 ± 0.5°C (mimicking human skin temperature).
Q-MF (containing ~5 mg quercetin) or QPLC-MF
(containing ~5 mg quercetin) was then placed over the
membrane. At regular intervals, aliquots (1 mL) of the
dissolution medium were removed, diluted suitably
with PBS (pH 7.4), and spectral absorbance recorded
at 381.2 nm. The measured absorbance was used to
estimate the cumulative amount of quercetin diffused
across the membrane.
Ex vivo skin permeation studies

The comparative permeation efficiencies of quercetin
from the quercetin-loaded matrix films (Q-MF) and
quercetin present in the prepared QPLC-loaded
matrix film (QPLC-MF) were determined using a
method reported previously by Parhi et. al. (32). The
Franz diffusion cell described above was used for the
experiments. On the day of experiment, a freshly
excised, hairless rat abdominal skin membrane was
prepared and hydrated in PBS (pH 7.4) for 1 hour.
The skin was mounted between the donor and the
receptor compartment with the stratum corneum
facing the donor compartment. Q-MF (containing
~5 mg quercetin) or QPLC-MF (containing ~5 mg
quercetin) was then placed on the skin surface (donor
compartment). The diffusion cell was placed on a
magnetic stirrer (200 RPM), and the temperature of
This Journal is © IPEC-Americas

In vivo anti-inflammatory studies

The prepared QPLC-loaded films were subjected to
preliminary pharmacological evaluation using the
carrageenan-induced rat paw edema model described
by Arora et. al. (33). In-house bred Albino rats
(Wistar strain, 200-250 g) of either sex were used for
the experiments. The animals were housed in clean
colony cages maintained at controlled temperature
(25 ± 5°C) and humidity (50 ± 5% RH) conditions
with 12-hour light/dark cycle. The food (Pellet chow,
Brook Bond, Lipton, India) and water was provided ad
libitum to all animals. The dorsal surface (back) of all
animals was shaved 12 hours prior to the experiment.
The Committee for the Purpose of Control and
Supervision of Experiments on Animals (CPCSEA)
ethical guidelines were followed when carrying out
the experimental protocol. The experimental protocol
(SKBCOP/IAEC/2016 -17, dated August 12, 2016)
was approved by the Institutional Animal Ethical
Committee (IAEC) of Smt. Kishoritai Bhoyar College
of Pharmacy, New Kamptee, Nagpur, Maharashtra,
India.
The animals were separated into three groups of six
animals each. The Group I animals received injections
of a homogenous suspension (0.1 mL, 1% w/v) of
carrageenan in double-distilled water, in the left hind
paw, and served as control. Q-MF (20 mg/kg quercetin)
and QPLC-MF (20 mg/kg quercetin) films were
applied to the back of group II and group III animals,
respectively. These animals also received injections of
carrageenan suspension in the left hind paw, half an
hour after the treatment with the test formulations. The
volume of paw edema was measured at 1, 2, 3, 4, 5, 6,
8, 10, and 12 hours using a digital plethysmometer (VJ
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InstrumentsTM, Washim, India). The inhibition (%) of
rat paw edema by the test formulations was calculated
using Equation 4.
Inhibition (%) =

edema ( control ) − edema ( test drug )
x 100
edema ( control )

Eq. 4

Statistical analysis

The results are presented as mean ± standard deviation.
ANOVA followed by post-hoc Dunnett’s or Student’s
t-test was used to assess the significance of difference
between groups. The value of p < 0.05 was considered
to indicate the statistically significant difference
between groups.

obtained from the 20 experimental trial formulations
suggested by the central composite design are shown in
Table 2. The prepared trial formulations showed a wide
range of quercetin inclusion ranging from 65 to 97%.
The data analyzing software (Design Expert®) displayed
the results numerically in the form of ANOVA and
a polynomial equation. For all the trial experiments,
both quadratic and cubic mathematical models were
displayed by the design. However, based on the analysis
of significance, the quadratic model was found to be a
more reliable description of the results. The obtained
polynomial, equation (Equation 5), containing the
magnitude of coefficients, together with the positive
(+) or negative (-) signs associated with them was used
to optimize the formulation.
Y = 95.31 + 7.55 X 1 − 6.07 X 2 + 1.78 X 3 − 7.22 X 12 − 4.82 X 22 −

RESULTS AND DISCUSSION

1.73 X 32 + 4.46 X 1 X 2 − 2.44 X 2 X 3 − 1.84 X 1 X 3

Formulation of quercetin-phospholipid complex
(QPLC)

Eq. 5

In the current study, a phospholipid-based complex of
quercetin was prepared by solvent evaporation method
to improve its aqueous solubility and physiological
delivery. Several studies have reported the hydrophobic
nature of flavonoids, resulting in sub-optimal aqueous
solubility of such compounds (28, 34, 35). These
studies recommended using dichloromethane,
tetrahydrofuran or 1, 4-dioxane as a choice of solvent
for preparing phospholipid-based complexes. However,
the observations from preliminary studies showed that
quercetin displayed poor solubility, and precipitated
out of DCM, THF and 1, 4-dioxane. Hence,
alternative solvents were explored to overcome this
challenge. Anhydrous ethanol being a semi polar, class
III solvent with low dielectric constant, was chosen as
solvent of choice for the formulation of QPLC. For the
preparation of the quercetin- or QPLC-loaded matrix
films a binary solvent combination of methanol:
chloroform (1:1) was found to be ideal.

Where, the coefficients b0, b1, b2, b11, b12, and b22
exhibited values with p<0.05, indicating their
significance. Whereas, the coefficients b3, b33, b23,
and b13 showed p>0.05 indicating that these terms
were non-significant. The summary statistics of
the model also showed the correlation coefficient
(R2 = 0.9908) and F-value (10.08) to be statistically
significant (p<0.05). The signs (+ or –) associated with
the coefficients indicated that quercetin inclusion in
the prepared formulations increased with increasing
X1 and X3, and decreased with increasing X2. Finally,
using a numerical optimization method, the levels
of independent variables used for trial formulation
number 6 (Table 2) with a desirability value close to 1
was selected to optimize the formulation. The influence
of the studied variables on the extent of quercetin
inclusion is shown in the form of response surface,
contour and desirability plots in Figure 1. The levels
of independent variables for this formulation were
quercetin: phospholipid at a ratio of 1:1.78, reaction
temperature at 50°C and reaction time of 2 hours.

Optimizing variables (central composite design)

Validation of the optimized model

The results of the quercetin inclusion efficiency

The above model was validated by preparing an
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Figure 1 The response surface plots, contour plots, and desirability plots of the extent
of complexation rate (Y, %) as a function of the ratio of quercetin and Phospholipon®
90H (X1, w:w), and the reaction temperature (X2, °C) and reaction time (X3, h).

additional QPLC formulation using the optimal values
of the variables. The obtained quercetin inclusion
(94.8%) in this formulation was comparable to the
model-predicted value (94.9%). The calculated bias,
using Equation 6, was found to be 0.12% (< 3%),
indicating the robustness and validity of the design
generated model.

suitable for oral drug delivery (27). The results of the
particle size analysis of the prepared QPLC formulation
are shown in Figure 2 (A). The mean particle size of the
prepared formulation was observed to be 95.74 ± 1.30
nm. The polydispersity index of these particles was
found to be 0.09 ± 0.01 nm, indicating a fairly narrow
size distribution.

predicted value − observed value
x 100
predicted value

Zeta potential (ζ) measures the distribution of charge
surrounding the particles, and potentially indicates the
physical stability of sub-micron particles dispersed in a
liquid (37). The zeta potential results of the prepared
QPLC formulation are displayed in Figure 2(B). The
zeta potential (ζ) for QPLC was – 4.85 ± 0.30 mV,
indicating fair stability of the colloidal dispersion.
The particle size, polydispersity index, and the zeta
potential results indicated that the prepared QPLC
exhibits relatively stable physical attributes.

Bias (%)=

Eq. 6

Physical-chemical characterization of QPLC
Particle size and zeta potential analysis

For sub-micron particles, particle size distribution
and zeta potential are important indicators of physical
stability of such particles when dispersed in a liquid
medium (27, 36). According to the earlier reports,
APLC formulation with particle size and PDI value
(107 nm and 0.37, respectively) was found to be
This Journal is © IPEC-Americas

Thermal analysis (DSC)

The thermograms obtained from the DSC analysis
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Figure 2 Particle size distribution (A) and zeta potential (B) of the optimized
QPLC formulation.

Figure 3 DSC thermograms of (A) pure quercetin, (B) Phospholipon® 90H, (C) the physical mixture (1:1.178)
of quercetin and Phospholipon® 90H, and (D) QPLC.
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of pure quercetin, Phospholipon® 90H, the physical
mixture of quercetin and Phospholipon® 90H, and
the prepared QPLC are shown in Figure 3 (A-D) for
comparison. As shown in Figure (3A), the thermogram
of pure quercetin revealed two dissimilar endothermic
peaks, each at ~130°C and ~318°C. The first peak was
likely obtained due to the evaporation of water (drying),
and the second peak can be attributed as the melting
peak of quercetin. The obtained results were found to
be consistent with the reports published earlier (38).
Pure Phospholipon® 90H (Figure 3B) exhibited a series
of five endothermic peaks at ~84°C, ~105°C, ~120 °C,
and ~238°C. The first three peaks are related to the
polar head groups of the phospholipid molecule, and
the latter two peaks with lower intensities appear to be
formed due to the transition of phospholipid from its
gel to a liquid crystal state. These peaks are characteristic
for Phospholipon® 90H and consistent with those
reported previously (23, 29). The thermogram of
the physical mixture (Figure 3C) displayed two
endothermic peaks i.e., at ~87°C and ~120°C. These
peaks appeared to be a combination of quercetin and
Phospholipon® 90 H. The melting peak obtained with
pure quercetin was absent in this thermogram. It is
likely that, at increasing temperatures the components
of the mixture reacted, resulting in the partial formation
of complex. The thermogram of the prepared QPLC
(Figure 3D) exhibited a completely new, single broad
endothermic peak at ~65°C. The original characteristic
peaks related to pure quercetin or pure Phospholipon®
90H were absent in this thermogram, indicating the
formation of a new entity. The findings were consistent
with published reports in literature (24, 28). These
observations lead us to conclude that in the prepared
QPLC, weak intermolecular interactions such as
hydrogen bonding, and van der Waals interactions
are established between the phenolic (-OH) groups
of quercetin and the functional groups of the
phospholipid molecule, resulting in the formation of
a stable complex (22, 39, 40).
Fourier transform infrared spectroscopy (FTIR)

The spectra obtained from the FTIR analysis of pure
This Journal is © IPEC-Americas

quercetin, Phospholipon® 90H, the physical mixture of
quercetin and Phospholipon® 90H, and the prepared
QPLC are shown in Figure 4 (A-D). Pure quercetin
revealed characteristic absorption bands at 3400.65
cm-1 and 3242.48 cm-1 (related to phenolic O-H
stretching) (Figure 4A). Other minor absorption bands
observed for quercetin included the ones at 1665.60
cm-1 and 1610.63 cm-1 (C=O stretching), 1560.48
cm-1 and 1521.90 cm-1 (aromatic stretching), and
1319.37 cm-1 and 1168.91 cm-1 (C-O-C stretching).
These observations were consistent with those reported
earlier (19, 21). The Phospholipon® 90H spectrum
showed strong absorption bands at 2917.46 cm-1 and
2849.95 cm-1 (C-H stretching associated with the long
chain fatty acids) (Figure 4B). Other observed peaks for
the phospholipid molecule were found at 1731.19 cm-1
(C=O stretching in the fatty ester), 1237.39 cm-1 (P=O
stretching), 1092.72 cm-1 (P-O-C stretching), and
970.24 cm-1 (-N+(CH2)3) (41). The physical mixture
of quercetin and Phospholipon® 90H exhibited
absorption bands associated with both compounds i.e.,
at 3290.11 cm-1, 2917.29 cm-1, 2849.95 cm-1, 1664.64
cm-1, 1610.63 cm-1, 1169.88 cm-1, 1240.28 cm-1,
1092.72 cm-1 and 970.24 cm-1, and consistent with an
earlier report on this binary mixture (Figure 4C) (42).
The FTIR spectrum of QPLC is shown in Figure 4D.
Major absorption bands were observed at 3318.67 cm1
, 2915.53 cm-1, 1563.37 cm-1, 1166.98 cm-1, 1094.65
cm-1 and 967.34 cm-1. This spectrum revealed some
peaks that were unique to QPLC, and some that
were associated with either the pure components or
the physical mixture of the components. The peaks
associated with the pure components or the physical
mixture was observed to be slightly shifted, possibly
due to the weak intermolecular interactions between
the two molecules during the formation of the complex.
Powder x-ray diffractometry (PXRD)

The comparative structural characteristics of pure
quercetin, Phospholipon® 90H, the physical mixture
of quercetin and Phospholipon® 90H, and the
prepared QPLC, as determined by PXRD analysis
are shown in the form of X-ray diffractograms in the
Figure 5 (A-D). Figure 5A shows the diffractogram of
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Figure 5 The x-ray diffractograms of (A) pure quercetin, (B)
Phospholipon® 90H, (C) the physical mixture (1:1.78) of quercetin and Phospholipon® 90H, and (D) QPLC.
Figure 4 FTIR spectra of (A) pure quercetin, (B) Phospholipon®
90H, (C) the physical mixture (1:1.78) of quercetin and
Phospholipon® 90H, and (D) QPLC.
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pure quercetin. Quercetin exhibited five sharp peaks
of high intensity at 11°, 12.5°, 16°, 24°, and 27° 2θ,
attributable to the crystalline nature of quercetin, and
have been observed earlier (17). The diffraction pattern
of pure Phospholipon® 90H revealed a single peak at
21° 2θ, indicating the partial-amorphous nature of
the compound (Figure 5B). These observation are
well supported by reports published earlier (23). The
physical mixture of quercetin and Phospholipon® 90H
showed a blend of peaks with varying intensities at
6°, 11°, 12.5°, 21°, and 27° 2θ (Figure 5C). The low
intensity peaks were similar to those observed with
pure quercetin; whereas, the single broad peak can be
assigned to the phospholipid molecule. The decreased
intensity of quercetin peaks in the physical mixture
has been reported to be caused by the lower amount
of quercetin in mixture, interference by phospholipid
molecule, in situ formation partial aggregates between
the components or partial complex formation (23).
The diffractogram of QPLC, as shown in Figure
5D, exhibited several closely associated peaks at 11°,
11.5°, 21°, and 25° 2θ. The pattern and separation
of peaks in this diffractogram appeared to closely
match that of pure Phospholipon® 90H. Moreover,
it is possible that the diffraction peaks observed are
due to any crystalline components remaining in the
prepared complex. It is assumed that, in the prepared
complex, quercetin is molecularly dispersed within
the phospholipid matrix resulting in a change in the
crystalline nature of quercetin. Not-surprisingly, the
intense crystalline peaks of quercetin is thus expected to
be suppressed, while the diffractogram predominantly
exhibits characteristic peaks of a partially amorphous
phospholipid molecule.
Proton nuclear magnetic resonance spectroscopy
(1H-NMR)

Comparative 1H-NMR spectra of pure quercetin,
Phospholipon® 90H, and QPLC are shown in Figure 6
(A, B, and C), respectively. The 1H-NMR spectrum of
Quercetin in d6-DMSO indicates the presence of five
phenyl protons across the flavone skeleton. Specifically,
these appear as doublets at δ 6.19 (H-6; J = 2 Hz), 6.42
(H-8; J = 2 Hz), 6.88 (H-6’; J = 2 Hz), 7.55 (H-2’; J
This Journal is © IPEC-Americas

Figure 6 1H-NMR spectra of (A) pure quercetin, (B)
Phospholipon® 90H, and (C) QPLC.

= 2 Hz), 7.68 (H-5’; J = 2 Hz). The chemical shifts of
three of the four phenolic protons (-OH at C-7, C-3’,
C-4’) appear as a broad singlet at δ 9.31. The –OH
proton at C-5 appears at δ 12.47, a downfield shift
that clearly suggests an intra-molecular hydrogen bond
with the C-4 oxygen atom. The 1H-NMR spectrum
of Phospholipon® 90H shows the protons in the alkyl
region at δ 1.24. When the chemical shifts of these
two 1H NMR spectra are compared with the 1H-NMR
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spectrum of QPLC, the following differences emerge:
(1) The δ 1.24 signal is distinctly lower in terms of
relative peak height intensity, and (2) the broad singlet
at δ 9.31 in the QPLC spectrum accounts for only
two phenolic protons, which suggests that the third
proton is exchanged with Phospholipon® 90H. All
other chemical shifts are intact. Thus, the spectral
comparisons confirm the complexation of quercetin
with the phospholipid matrix to form the QPLC.

AQUEOUS
SOLUBILITY
(µg/mL)

n-OCTANOL
SOLUBILITY
(µg/mL)

2.56 ± 0.45

857.28 ± 0.76

Quercetin: Phospholipon 90H
(1:1.78)

31.90 ± 1.12

890.73 ± 0.91

QPLC

58.50 ± 1.02

910.90 ± 1.15

SAMPLES
Pure quercetin
®

Physical-chemical characterization of QPLC-MF

Solubility analysis

The results obtained from the aqueous and non-aqueous
solubility analysis of pure quercetin, the physical
mixture of quercetin with Phospholipon® 90H (1:1.78),
and the optimized QPLC formulation are shown in
Table 3. The aqueous solubility of pure quercetin
was found to be ~2.5 μg/mL; whereas, its solubility
in n-octanol was observed to be ~855 μg/mL. These
observations are consistent with the fact that quercetin
is a lipophilic compound. The aqueous solubility of
quercetin in the physical mixture was found to be ~30
μg/mL, and significantly (p<0.01) higher than that of
pure quercetin. This increase (over 10-fold) in aqueous
solubility of quercetin in the physical mixture could
be attributed to the close association of amphiphilic
phospholipid molecules around quercetin. Quercetin
also exhibited a moderate, albeit non-significant
increase in n-octanol solubility (~890 μg/mL) in the
physical mixture. The aqueous solubility of quercetin
in the prepared QPLC was found to be significantly
(p<0.001) higher than that of pure quercetin, or
quercetin in the physical mixture (~57 μg/mL). The
association of lipophilic quercetin molecules with the
amphiphilic phospholipid molecules, and possible
partial amorphization of quercetin could explain
this dramatic (over 22-fold) increase in the aqueous
solubility of quercetin in the prepared complex. The
non-aqueous solubility of quercetin was also found to
be moderately increased (~910 μg/mL).

This Journal is © IPEC-Americas

Table 3 Aqueous and non-aqueous solubility of pure quercetin,
the physical mixture of quercetin with Phospholipon® 90H, and
the optimized QPLC formulation.

The results of physical-chemical characterization of
the prepared QPLC-loaded matrix films are discussed
below. The average thickness of the prepared films
was found to be 160.9 ± 11.2 µm. The average weight
of the films was observed to be 17.02 ± 1.4 mg. The
folding endurance test results showed that the prepared
QPLC films survived an average of 230 ± 1.45 strokes
of folding/unfolding at the same location before
demonstrating any appearance of racking/breaking.
These observations are considered to be acceptable
for similar formulations (30). These results showed
that when applied on the skin surface the film would
endure general movements and maintain its integrity.
The average moisture content (% w/w) of the films
maintained at controlled temperatures (25°C) was
found to be 1.24 ± 0.65. This moisture level is not
expected to influence the physical-chemical stability
of the formulation. The average maximum moisture
uptake (% w/w) of the films subjected to higher
humidity (75% RH) was 8.51 ± 1.08. The increase in
moisture uptake was possibly due to the presence of
HPMC E15 as a component of the films, and has been
reported earlier (30). These films may thus be required
to be packaged/stored in moisture-free environment.
The quercetin content of the films was 1.21 ± 0.031
mg.
Functional characterization of QPLC and QPLC-MF
In vitro dissolution studies

The comparative dissolution profiles of pure quercetin
and QPLC are shown in Figure 7. The dissolution
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Figure 7 The in vitro dissolution profiles of pure quercetin and QPLC. Values are mean ± Standard Deviation (n = 3).

Figure 8 The in vitro diffusion profiles of pure quercetin-loaded matrix films (Q-MF) and QPLC-loaded matrix films
QPLC-MF. Values are mean ± Standard Deviation (n = 3).
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rates of pure quercetin and quercetin in QPLC were
found to be similar during the initial 3 hours, beyond
which, QPLC exhibited a progressively increasing,
and a significantly higher rate and extent of quercetin
dissolution. At the end of 12 hours, pure quercetin
showed ~69 % dissolution. In the same time period,
over 90 % quercetin was released from QPLC. The
observed increase in rate and extent of quercetin from
QPLC can be attributed to the enhanced wettability
and solubility of quercetin in the presence of
amphiphilic phospholipid molecules, and is consistent
with earlier reports (43). Various release-kinetics
models such as zero order, first order, Higuchi, and
Korsmeyer-Peppas, etc. were evaluated to describe
the release mechanism of quercetin. Upon statistical
evaluation of the models, Korsmeyer-Peppas model
was observed to be the best-fitting kinetic model with
a regression coefficient of R2 = 0.9979 and the release
exponent n = 0.88. The model describes the dissolution
as a ‘non-fickian’ release mechanism correlating with
the diffusion process. This process is known to occur
in two stages, i.e., dissociation of quercetin molecule
from QPLC, and diffusion of quercetin molecules
across the phospholipid matrix (22, 44).
In vitro diffusion studies

Figure 8 shows the comparative in vitro diffusion
profiles of quercetin from Q-MF and QPLC-MF
across dialysis membrane. QPLC-loaded films
exhibited a significantly higher rate and extent of
quercetin diffusion compared to that observed from
pure quercetin-loaded films at all tested time points. At
the end of the 12-hour testing period, only about 60%
of quercetin was found to diffuse across the membrane
from Q-MF, compared to over 80% diffusion of
quercetin observed with QPLC-MF. As seen with the
dissolution results, we assume that close proximity of
quercetin to the phospholipid molecules in QPLC-MF
was likely reason for the higher diffusivity of quercetin
from these films. In addition, previous studies have
reported that other film components, i.e., hydrophilic
polymers, plasticizers, penetration enhancers etc.
could also potentially influence the diffusion of drug
through the films (32, 45, 46). Thus, the components
This Journal is © IPEC-Americas

used to prepare the films in the current study, HPMC
E15 (hydrophilic matrix forming polymer), dibutyl
phthalate (plasticizer), and dimethyl sulfoxide
(penetration enhancer) may have likely contributed to
quercetin diffusion.
Ex vivo skin permeation studies

A comparison of quercetin permeability across isolated
rat abdominal skin from Q-MF and QPLC-MF is
shown in Figure 9. As observed with the diffusion
results, QPLC-loaded films exhibited a significantly
higher rate and extent of quercetin permeation
compared to that observed from pure quercetin-loaded
films at all tested time points. At the end of the 12hour testing period, more than 85 % of the quercetin
from the QPLC-MF was found to permeate across
the skin, compared to only about 65% of quercetin
permeability observed with Q-MF. The differences in
the permeability profiles of Q-MF and QPLC-MF
were statistically significant (p<0.01). As described
above, a combination of phospholipid-complexation
and permeation-promoting film components can be
considered as contributing factors to the observed
enhanced quercetin permeability from QPLC-loaded
films.
In vivo anti-inflammatory studies

The preliminary pharmacological evaluation of the
prepared films was conducted using carrageenaninduced paw edema in Wistar rats to assess the antiinflammatory potential of quercetin. The results
obtained are shown in Figure 10. The group I animals
subjected to carrageenan-alone treatment showed a
progressively increasing paw-edema (swelling of the
paw), exhibited as increasing paw volume over a period
of 12 hours. The animals receiving Q-MF (group II) or
QPLC-MF (group III) before carrageenan injections
showed a significant (p<0.05) protection against
carrageenan-induced inflammatory swelling. This
protection was found to be significant over the entire
observation period of 12 hours. The difference between
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Figure 9 The ex vivo skin permeation of quercetin from pure quercetin-loaded matrix films (Q-MF) and QPLC-loaded
matrix films QPLC-MF. Values are mean ± Stdandard Deviation (n = 3).

Figure 10 The in vivo anti-inflammatory activity of quercetin-loaded film and QPLC-loaded film on carrageenan-induced paw edema in rats. Values are mean ± Stdandard Deviation (n = 6).
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the protective effects of Q-MF and QPLC-MF was not
statistically significant. However, QPLC-MF appeared
to be slightly more efficacious than Q-MF. These results
supports the observations from the in vitro and ex vivo
results showing increased solubility and permeability
of quercetin from the prepared QPLC-loaded films. It
can thus be inferred that phospholipid complexation,
combined with incorporation of the complex in a
film formulation enhanced the in vivo bioavailability
of quercetin, resulting in pharmacological efficacy via
transdermal route.
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